Posters

Post uveitic cataract: treatment at Hassan II Hospital university in Fez about 30 cases

Poster Details

First Author: S.Idrissa MOROCCO

Co Author(s): L. Naoufal   L. Omar   A. Bennis   F. Chraibi   A. Meriem   B. Idriss     

Abstract Details

Purpose:

Cataract complicates 40% of uveitis in all etiologies, it occurs as a complication secondary to intraocular inflammation (chronic or recurrent), and long-term use of corticosteroids. The purpose of our work is to study the clinical and therapeutic particularities and the postoperative complications of these cataracts.

Setting:

The study is made in ophtalmology departement at hassan II University hospital, Fez Morocco

Methods:

Retrospective study of 30 cases of post uveitic cataracts, collected at the ophthalmology department at Hospital University Hassan II in Fez, between January 2009 and December 2017 (during a period of 9 years). All our patients benefited from a phacoemulsification surgical treatment after a lull period of 3 months.

Results:

The average age of our patients is 30.5 years. The most common etiology was Behçet's disease, however, 70% of cases had idiopathic uveitis. Bilateral involvement was found in 19 patients (63.3%). Total uveitis was the most common in our series at 63.3% of cases. Phacoemulsification is performed in all our patients, associated with implantation in 96.7% of cases. The capsular bag was the implantation site in 80% of the cases. Postoperative visual acuity is ≥ 1/10 at 53.3%, of which 20% had visual acuity greater than 5/10. the opacification of the posterior capsule is the most successful postoperative complication (33,3%)

Conclusions:

Phacoemulsification with intraocular implantation has become the main surgical method for the treatment of post uveitic cataract. The eye must be in lull for at least 3 months and under preventive corticotherapy before the surgical act. The success of cataract surgery is closely related to the careful control of preoperative inflammation. Surgery is well tolerated regardless of the type of uveitis if the inflammation is perfectly controlled preoperatively.

Financial Disclosure:

None